We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-0.37%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.43B
AUM Growth
-$12.4M
Cap. Flow
+$4.15M
Cap. Flow %
0.29%
Top 10 Hldgs %
31.81%
Holding
213
New
9
Increased
90
Reduced
54
Closed
8

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.73M
2
AZO icon
AutoZone
AZO
+$2.2M
3
MTB icon
M&T Bank
MTB
+$1.73M
4
HXL icon
Hexcel
HXL
+$1.65M
5
GILD icon
Gilead Sciences
GILD
+$934K

Top Sells

Rank Stock Value
1
EBAY icon
eBay
EBAY
+$1.8M
2
MSFT icon
Microsoft
MSFT
+$1.75M
3
PYPL icon
PayPal
PYPL
+$1.41M
4
BC icon
Brunswick
BC
+$1.29M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$1.29M

Sector Composition

Rank Sector Weight
1 Technology 29.17%
2 Healthcare 14.99%
3 Financials 13.22%
4 Industrials 12.54%
5 Consumer Staples 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$326B
$23.2M 1.62%
309,279
-4,274
-1% -$325K
CACI icon
27
CACI
CACI
$11.3B
$22.6M 1.58%
86,188
+3,476
+4% +$898K
WY icon
28
Weyerhaeuser
WY
$17.7B
$21.2M 1.48%
596,919
-20,797
-3% -$728K
BC icon
29
Brunswick
BC
$5.33B
$19.3M 1.35%
202,486
-12,990
-6% -$1.29M
ZBH icon
30
Zimmer Biomet
ZBH
$18.5B
$18.7M 1.3%
131,391
-230
-0.2% -$33.8K
MTB icon
31
M&T Bank
MTB
$36.6B
$18.1M 1.26%
120,959
+12,448
+11% +$1.73M
PG icon
32
Procter & Gamble
PG
$347B
$17.2M 1.2%
123,015
-4,606
-4% -$653K
JNJ icon
33
Johnson & Johnson
JNJ
$643B
$17.1M 1.2%
106,010
+1,766
+2% +$301K
FDX icon
34
FedEx
FDX
$74B
$17.1M 1.19%
77,955
-1,430
-2% -$388K
PPG icon
35
PPG Industries
PPG
$26.5B
$16.5M 1.15%
115,520
+1,607
+1% +$258K
GILD icon
36
Gilead Sciences
GILD
$167B
$16.5M 1.15%
236,254
+13,290
+6% +$934K
HXL icon
37
Hexcel
HXL
$8.3B
$16.4M 1.14%
276,222
+28,585
+12% +$1.65M
WLY icon
38
John Wiley & Sons Class A
WLY
$2.76B
$16.1M 1.13%
309,038
+1,733
+0.6% +$99.3K
SNY icon
39
Sanofi
SNY
$109B
$15.8M 1.1%
328,014
+4,977
+2% +$253K
REGN icon
40
Regeneron Pharmaceuticals
REGN
$72.9B
$15.8M 1.1%
26,031
+4,395
+20% +$2.73M
AAPL icon
41
Apple
AAPL
$4.99T
$15.3M 1.07%
108,024
+1,077
+1% +$159K
CVX icon
42
Chevron
CVX
$374B
$13.4M 0.94%
132,534
+3,577
+3% +$357K
CTSH icon
43
Cognizant
CTSH
$23.8B
$13M 0.91%
174,721
-6,409
-4% -$473K
TMO icon
44
Thermo Fisher Scientific
TMO
$214B
$12.7M 0.89%
22,276
+350
+2% +$192K
GLW icon
45
Corning
GLW
$108B
$12.7M 0.89%
348,483
+8,322
+2% +$332K
DVN icon
46
Devon Energy
DVN
$49.2B
$11.9M 0.83%
336,609
-1,103
-0.3% -$31.3K
NVS icon
47
Novartis
NVS
$304B
$10.3M 0.72%
125,645
-7,294
-5% -$656K
RDS.B
48
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$9.68M 0.68%
218,623
+1,951
+0.9% +$77.2K
XOM icon
49
ExxonMobil
XOM
$634B
$9.42M 0.66%
160,195
+4,017
+3% +$229K
BLKB icon
50
Blackbaud
BLKB
$1.65B
$8.77M 0.61%
124,720
+12,547
+11% +$883K

Similar funds

Grandfield & Dodd's Q3 2021 Portfolio in Review

As of Q3 2021, Grandfield & Dodd held 213 positions worth $1.43B, down 0.86% from $1.45B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q3 2021 filing shows 9 new, 90 increased, 54 reduced and 8 closed positions. Its largest new stake was AutoZone: 1,373 shares worth $2.33M. The largest sale was eBay, an estimated $1.8M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q3 2021 buy was AutoZone: 1,373 shares worth $2.33M.
  • Grandfield & Dodd added most to Regeneron Pharmaceuticals in Q3 2021, an estimated $2.73M increase.
  • Grandfield & Dodd's biggest Q3 2021 reduction was eBay, cutting an estimated $1.8M.
  • Grandfield & Dodd fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.29M.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.43B portfolio in Q3 2021.
  • Grandfield & Dodd opened 9 new positions and closed 8 in Q3 2021.
  • Grandfield & Dodd's portfolio value fell 0.86% quarter-over-quarter to $1.43B.

Based on Grandfield & Dodd's 13F filing for Q3 2021, filed 28 Oct 2021.